Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

303 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelial function in sustained and white coat hypertension.
Pierdomenico SD, Cipollone F, Lapenna D, Bucci A, Cuccurullo F, Mezzetti A. Pierdomenico SD, et al. Among authors: mezzetti a. Am J Hypertens. 2002 Nov;15(11):946-52. doi: 10.1016/s0895-7061(02)02993-x. Am J Hypertens. 2002. PMID: 12441213
Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control.
Cipollone F, Chiarelli F, Davì G, Ferri C, Desideri G, Fazia M, Iezzi A, Santilli F, Pini B, Cuccurullo C, Tumini S, Del Ponte A, Santucci A, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: mezzetti a. Diabetologia. 2005 Jun;48(6):1216-24. doi: 10.1007/s00125-005-1750-2. Epub 2005 May 3. Diabetologia. 2005. PMID: 15868137
Preprocedural level of soluble CD40L is predictive of enhanced inflammatory response and restenosis after coronary angioplasty.
Cipollone F, Ferri C, Desideri G, Paloscia L, Materazzo G, Mascellanti M, Fazia M, Iezzi A, Cuccurullo C, Pini B, Bucci M, Santucci A, Cuccurullo F, Mezzetti A. Cipollone F, et al. Among authors: mezzetti a. Circulation. 2003 Dec 2;108(22):2776-82. doi: 10.1161/01.CIR.0000103700.05109.0D. Epub 2003 Nov 17. Circulation. 2003. PMID: 14623801 Clinical Trial.
Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
Santilli F, Davì G, Consoli A, Cipollone F, Mezzetti A, Falco A, Taraborelli T, Devangelio E, Ciabattoni G, Basili S, Patrono C. Santilli F, et al. Among authors: mezzetti a. J Am Coll Cardiol. 2006 Jan 17;47(2):391-7. doi: 10.1016/j.jacc.2005.03.079. Epub 2005 Dec 20. J Am Coll Cardiol. 2006. PMID: 16412866 Free article. Clinical Trial.
Overexpression of microRNA-145 in atherosclerotic plaques from hypertensive patients.
Santovito D, Mandolini C, Marcantonio P, De Nardis V, Bucci M, Paganelli C, Magnacca F, Ucchino S, Mastroiacovo D, Desideri G, Mezzetti A, Cipollone F. Santovito D, et al. Among authors: mezzetti a. Expert Opin Ther Targets. 2013 Mar;17(3):217-23. doi: 10.1517/14728222.2013.745512. Epub 2013 Jan 23. Expert Opin Ther Targets. 2013. PMID: 23339529
COX-2 and the vasculature: angel or evil?
Cuccurullo C, Mezzetti A, Cipollone F. Cuccurullo C, et al. Among authors: mezzetti a. Curr Hypertens Rep. 2007 Mar;9(1):73-80. doi: 10.1007/s11906-007-0013-7. Curr Hypertens Rep. 2007. PMID: 17362675 Review.
COX-2: friend or foe?
Iezzi A, Ferri C, Mezzetti A, Cipollone F. Iezzi A, et al. Among authors: mezzetti a. Curr Pharm Des. 2007;13(16):1715-21. doi: 10.2174/138161207780831293. Curr Pharm Des. 2007. PMID: 17584101 Review.
303 results